CRISPR IP Considerations

When and where

Date and time

Start: Tuesday 30 June 2020, 12:30 PM

End: Tuesday 30 June 2020, 01:30 PM

Event Overview

Ever wondered why CRISPR is at the forefront of multiple patent interferences in the US and contentious proceedings before the EPO? This webinar will explain for those not familiar with the technology why there is such interest, will give a short overview of the IP battles aimed at all patent attorneys and, for those working in life sciences, will finish with some considerations when drafting in this field.

Audience

Fellows, Students

Speakers

Cath Coombes, Murgitroyd

Cath Coombes is a Director, Patents at Murgitroyd. She has a particular interest in CRISPR technology having spent over a decade being involved in oppositions and prosecution of patent applications in this field. Her experience encompasses early patents in this field manipulating CRISPR as an innate bacterial immune system to gene editing applications, diagnostics and antimicrobial applications. She has written numerous articles on CRISPR and provides comments on CRISPR IP for various journals, such as Nature, Science and The Scientist.

CRISPR IP Considerations

When and where

Date and time

Event Overview

Audience

Speakers

Cath Coombes, Murgitroyd

Other events

Webinar

Date and time

CPD Included

Congress

Date and time

CPD Included

Webinar

Date and time

CPD Included

Social

Date and time

Regional Meeting

Date and time

CPD Included

Webinar

Date and time

CPD Included

Seminar

Date and time

CPD Included

Webinar

Date and time

CPD Included

Congress

Date and time

CPD Included

Regional Meeting

Date and time

CPD Included

CRISPR IP Considerations

Shopping Basket

Are you a CIPA member?